How did MODG's Q4 earnings surprise impact its annual performance?

Moderna's (MODG) fourth-quarter (Q4) earnings beat expectations had a mixed impact on its annual performance, with positive short-term gains but underperformance in the long term. 1. **Short-Term Gains**: Following the earnings beat announcement, there was a positive reaction in the stock price, with a maximum return of 3.35% observed within 30 days. This suggests that investors appreciated the company's performance and potential outlook. 2. **Underperformance in the Long Term**: However, when examining the longer-term performance, the stock experienced a decline, with returns of -0.53% and -1.12% observed in the 3-day and 10-day periods following the earnings release. This indicates that while there was initial optimism, it may have been tempered by broader market conditions or concerns about the company's future prospects. 3. **Annual Performance**: Considering the annual performance, the impact of the Q4 earnings beat expectations on the overall annual net income and EPS is not explicitly provided. However, the mixed short-term returns suggest that while there may have been some positive momentum, it did not necessarily translate into significant annual growth. In conclusion, while Moderna's Q4 earnings beat expectations led to short-term gains in the stock price, the impact on the annual performance was muted, with the stock underperforming in the long term. This indicates that factors other than earnings performance may be influencing the stock's annual returns.